Breaking News: FNDX to Conduct Second Pilot Run

COMPANY UPDATES - FendX Technologies (FDXTF:OTC, FNDX:CSE)

FendX Technologies recently announced a new collaboration with manufacturing partner Dunmore Corporation to further scale up and optimize their innovative REPELWRAPTM antimicrobial nano-film.

This marks the second developmental agreement between FendX and Dunmore, building on the success of their initial pilot run which confirmed the REPELWRAP^TM formula can be effectively manufactured at an intermediate scale using automated processes.

According to FendX CEO Dr. Carolyn Myers, this next phase will focus on additional refinements to the film as well as expanded real-world testing beyond lab conditions.

The company views collaborations like this developmental partnership with Dunmore as invaluable progress towards their goal of commercializing REPELWRAP^TM for professional use in healthcare facilities, schools, offices, and other sectors.

FendX stated that the positive results from the first Dunmore pilot run were a key milestone, providing crucial confirmation that their patent-pending technology can be scaled-up for industrial production.

With Dunmore's expertise and these expanded trials, FendX aims to gather further validation of REPELWRAP's viability as a next-generation antimicrobial solution as they march steadily down the path towards bringing this technology to market.

» Read the full press release and get a stock quote here.

Sincerely,

The Investing Insider Team
InvestingInsider.com

P.S. Want to learn more about FendX Technologies and how it’s patent-pending nanotechnology instantly repels viruses, bacteria, and even the strongest superbugs?

 Click Here for the Full Company Report.

This publisher has been compensated for this distribution. Please refer to "Important Notice and Disclaimer" at the bottom of this report for important additional information, risk factors, and information sources.